Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

about

A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.

P2860

Q55287219-8293AC4A-606D-4886-BB23-1AF14F8E2F87

P2860

Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

Item

http://www.wikidata.org/entity/Q48188242

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@en

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@nl

type

Item

label

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@en

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@nl

prefLabel

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@en

Adoptive transfer of murine T ...... an immunotherapy for lymphoma.

@nl

P1476

Adoptive transfer of murine T ...... an immunotherapy for lymphoma

@en

P2093

Adam Lynch

http://www.w3.org/2001/XMLSchema#string

Emily Nylen

http://www.w3.org/2001/XMLSchema#string

Sean Ober

http://www.w3.org/2001/XMLSchema#string

William Hawk

http://www.w3.org/2001/XMLSchema#string

P2860

Immune Checkpoint Blockade in Cancer Therapy

Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells

The blockade of immune checkpoints in cancer immunotherapy

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination

Toxicity and management in CAR T-cell therapy

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

T cell exhaustion

Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.

P304

472-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMM.12784

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Autin

Amorette Barber

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28670716

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5629437

http://www.w3.org/2001/XMLSchema#string

Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

about

P2860

P2860

Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932